Does Rallies show Form 4 insider transactions for SEER?

Yes. Rallies tracks SEER insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SEER research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SEER. It does not provide personalized investment advice.

SEER (Seer, Inc. Class A Common Stock) Stock Analysis - Insider Trades

Seer, Inc. Class A Common Stock (SEER) is a publicly traded Healthcare sector company. As of May 21, 2026, SEER trades at $1.70 with a market cap of $92.92M and a P/E ratio of 0.00. SEER moved +0.00% today. Year to date, SEER is -8.70%; over the trailing twelve months it is -19.62%. Its 52-week range spans $1.62 to $2.63. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces SEER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SEER stock inside the company?

Recent SEER insider activity includes Horn David R. sold 7.74K, Farokhzad Omid sold 24.39K, Horn David R. sold 6.80K, Farokhzad Omid sold 33.84K, and Horn David R. sold 6.83K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SEER Key Metrics

Key financial metrics for SEER
Metric	Value
Price	$1.70
Market Cap	$92.92M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$2.63
52-Week Low	$1.62
Volume	0
Avg Volume	0
Revenue (TTM)	$15.17M
Net Income	$-70.49M
Gross Margin	48.70%

Recent SEER Insider Trades

Horn David R. sold 7.74K (~$15.45K) on Feb 18, 2026.
Farokhzad Omid sold 24.39K (~$48.65K) on Feb 18, 2026.
Horn David R. sold 6.80K (~$13.40K) on Nov 19, 2025.
Farokhzad Omid sold 33.84K (~$66.71K) on Nov 19, 2025.
Horn David R. sold 6.83K (~$13.96K) on Aug 20, 2025.

Latest SEER News

Seer Q1 Revenue Falls 34% to $2.8M as Net Loss Narrows — May 13, 2026
Seer Appoints Former Biologos CEO Anthony Bazarko as Chief Commercial Officer — May 4, 2026
Seer’s Proteograph to Profile Plasma Proteome in 10,000 PRECISE-SG100K Samples — Apr 9, 2026
Seer Retains 23 Claims in U.S. Proteograph Patent, Bolsters IP Portfolio — Mar 30, 2026
Seer Q4 Revenue Grows 17%, Instrument Base Up 67%, AI-PAS Gen 4 Due 2026 — Feb 27, 2026

SEER Analyst Consensus

2 analysts cover SEER: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Common questions about SEER

Who is trading SEER stock inside the company?: Recent SEER insider activity includes Horn David R. sold 7.74K, Farokhzad Omid sold 24.39K, Horn David R. sold 6.80K, Farokhzad Omid sold 33.84K, and Horn David R. sold 6.83K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SEER?: Yes. Rallies tracks SEER insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SEER research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SEER. It does not provide personalized investment advice.